RankAlpha logo
Back to Rankings

CHRS

Coherus OncologyF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
CHRS vs peer average
34/100
CHRS vs. peer average (F vs. D)
Grade spread
B 1 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CRBU is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $230.1M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCRBUCaribou Biosciences
CHRS
Coherus Oncology
CRBU
Caribou Biosciences
Grade
F
F
Momentum
18
5
Value
44
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs CRBU

CHRS / CRBU
Grade Position
Below peers
CHRS vs. peer average (F vs. D)
34/100
Momentum
18
CHRS
Value
44
CHRS
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CHRS
1
CRBU
Caribou Biosciences Inc Common
F
20/100
Even
2
ALXO
ALX Oncology Holdings Inc Common
F
20/100
Even
3
SLGL
Sol-Gel Technologies Ltd Common
C
60/100
-2
4
YDES
Breeze Holdings Acquisition Corp Common
N/A
-
-
5
INDP
Indaptus Therapeutics Inc Common
D
40/100
-1
CRBU is the first peer returned for this comparison set.